Avacta adds range of rapid tests with Coris Bioconcept acquisition
Avacta Group has acquired Coris Bioconcept for £7.4 million and an extra £3 million payout based on future business performance.
This author has yet to write their bio.
Avacta Group has acquired Coris Bioconcept for £7.4 million and an extra £3 million payout based on future business performance.
TRIMERO Diagnostics offers Retinol Binding Protein IVD CE marked assays, for serum and urine samples, available for Beckman Coulter’s IMMAGE® nephelometers and the most popular Clinical Chemistry analyzers present in the market.
Indica Labs is now offering its HALO digital pathology software portfolio as a fully managed cloud-hosted environment powered by Amazon Web Services (AWS). The service enables organizations to benefit from Indica Labs’ software development and cloud deployment expertise while maintaining full ownership and control over their AWS account.
Danish biotech Tetra Pharm Technologies announced promising results from a pre-clinical in vitro trial of its pain-relieving drug – TPT0301 – using a novel drug delivery technology. It was compared against more commonly used formulations for drug delivery in the oral cavity.
Beckman Coulter Life Sciences has introduced a new Light Array Module (LAM) for the BioLector XT Microbioreactor which is set to advance research with a wide range of phototrophic organisms.
LynxDx, a Michigan diagnostics laboratory specializing in prostate cancer screening and risk prediction, acquired liquid handling solutions from INTEGRA Biosciences to streamline its sample preparation for high throughput COVID-19 testing. The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and […]
DiaSys successfully introduced Total bile acids 21 FS to determine total bile acids (TBA) in serum. Now, without altering the reagent composition and the highly sensitive enzymatic cycling method, the scope of the test has been expanded to detect TBA in human stool samples.
Antibodies against Epstein-Barr virus (EBV), a common virus that most people acquire early in life, are linked to multiple sclerosis (MS). This is shown in a study from the Karolinska Institutet, where technology from the biotech company Neogap Therapeutics has been used to map immune cells reactive to EBV and autoantigens related to MS.
AP 16 IF ELITE is an innovative, fast automated processor able to tun 16/20 IFA slides, it’s equipped with a sliding-sample barcode reader and a camera for the slide code reading.
TRIMERO Diagnostics offers C1q, C5, C1 (Esterase) Inhibitor and Factor B (C3 Proactivator) IVD CE marked assays on: Beckman Coulter’s IMMAGE® Immunochemical Systems Siemens Healthcare’s BN™ Series and Atellica® NEPH 630 nephelometers Clinical Chemistry Analyzers
November 2024
The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy